HCAT - Health Catalyst - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HCAT is currently covered by 12 analysts with an average price target of $6.26. This is a potential upside of $3.81 (155.51%) from yesterday's end of day stock price of $2.45.

Health Catalyst's activity chart (see below) currently has 226 price targets and 173 ratings on display. The stock rating distribution of HCAT is 51.72% BUY and 48.28% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.67% with an average time for these price targets to be met of 110.16 days.

Highest price target for HCAT is $9, Lowest price target is $3, average price target is $5.1.

Most recent stock forecast was given by DAVID GROSSMAN from STIFEL on 11-Nov-2025. First documented stock forecast 19-Aug-2019.

Currently out of the existing stock ratings of HCAT, 15 are a BUY (51.72%), 14 are a HOLD (48.28%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 05-Aug-2022

$3.75

$1.47 (64.47%)

$5.5

1 months 29 days ago
(11-Nov-2025)

3/11 (27.27%)

$0.9 (31.58%)

57

Buy

Since 04-Apr-2023

$5

$2.72 (119.30%)

$6

1 months 29 days ago
(11-Nov-2025)

2/7 (28.57%)

$2.15 (75.44%)

9

Hold

Since 11-Nov-2025

$3.25

$0.97 (42.54%)

$6.5

1 months 29 days ago
(11-Nov-2025)

3/13 (23.08%)

$0.4 (14.04%)

269

Buy

Since 20-Apr-2023

$4

$1.72 (75.44%)

$5

3 months 1 days ago
(08-Oct-2025)

0/5 (0%)

$1.15 (40.35%)

Hold

Since 09-Apr-2025

$3

$0.72 (31.58%)

$4

3 months 1 days ago
(08-Oct-2025)

7/12 (58.33%)

$0.15 (5.26%)

41

Show more analysts

Please expand the browser size to see the chart

What is HCAT (Health Catalyst) average time for price targets to be met?

On average it took 110.16 days on average for the stock forecasts to be realized with a an average price target met ratio 35.67

Which analyst has the current highest performing score on HCAT (Health Catalyst) with a proven track record?

STEVEN HALPER

Which analyst has the most public recommendations on HCAT (Health Catalyst)?

Steven Halper has 29 price targets and 21 ratings on HCAT

Which analyst is the currently most bullish on HCAT (Health Catalyst)?

Sandy Draper with highest potential upside - $50.22

Which analyst is the currently most reserved on HCAT (Health Catalyst)?

David Larsen with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?